Spontaneous regression of chronic lymphocytic leukemia to a monoclonal B-lymphocytosis or to a normal phenotype

References

• Del Giudice I, Chiaretti S, Tavolaro S, et al. Spontaneous regression of chronic lymphocytic leukemia:clinical and biologic features of 9 cases. Blood 2009;114:638–646.
   PubMed Web of Science ®Google Scholar
• Hansen RM, Libnoch JA. Remission of chronic lymphocytic leukemia after smallpox vaccination. Arch Intern Med 1978;138:1137–1138.
   PubMed Web of Science ®Google Scholar
• Yettra M. Remission of chronic lymphocytic leukemia after smallpox vaccination. Arch Intern Med 1979;139:603.
   PubMed Web of Science ®Google Scholar
• DiStefano AD, Buzdar AU. Viral-induced remission in chronic lymphocytic leukemia? Arch Intern Med 1979;139:946.
   PubMed Web of Science ®Google Scholar
• DiStefano AD, Buzdar AU. Viral-induced remission in chronic lymphocytic leukemia? Arch Intern Med 1979;139:946.
   PubMed Web of Science ®Google Scholar
• Gomez Garcia EB, van Lochem EG, van Lom K, et al. Spontaneous remission of B-chronic lymphocytic leukaemia. Br J Haematol 2002;119:874–875.
   PubMed Web of Science ®Google Scholar
• Denes AE, Shalhav AL, Kovacs G, et al. Chronic lymphocytic leukemia remission following extra corporeal shock wave lithotripsy for urinary calculi. Am J Hematol 1998;58:239–240.
   PubMed Web of Science ®Google Scholar
• Wiernik PH. Spontaneous regression of hematologic cancers. Natl Cancer Inst Monogr 1976;44:35–38.
   PubMedGoogle Scholar
• Wiernik PH. Second neoplasms in patients with chronic lymphocytic leukemia. Curr Treat Options Oncol 2004;5:215–223.
   PubMedGoogle Scholar
• Bernard M, Drenou B, Pangault C, et al. Spontaneous phenotypic and molecular blood remission in a case of chronic lymphocytic leukaemia. Br J Haematol 1999;107:213–214.
   PubMed Web of Science ®Google Scholar
• Buchi G, Termine G, Zappala C, et al. Spontaneous complete remission of CLL. Report of a case studied with monoclonal antibodies. Acta Haematol 1983;70:198–201.
   PubMed Web of Science ®Google Scholar
• Herishanu Y, Solar I, Ben-Ezra J, et al. Complete spontaneous regression of chronic lymphocytic leukemia. J Clin Oncol 2012;30: e254–e256.
   Web of Science ®Google Scholar
• Holmes JA, Whittaker JA. Spontaneous remission in chronic lymphocytic leukaemia. Br J Haematol 1988;69:97–98.
   PubMed Web of Science ®Google Scholar
• Mehta J, Singhal S, Mehta BC. Spontaneous complete remission in chronic lymphocytic leukaemia. J Assoc Physicians India 1991;39:714.
   PubMedGoogle Scholar
• Ribera JM, Vinolas N, Urbano-Ispizua A, et al. “Spontaneous” complete remissions in chronic lymphocytic leukemia: report of three cases and review of the literature. Blood Cells 1987;12:471–483.
   PubMedGoogle Scholar
• Thomas R, Ribeiro I, Shepherd P, et al. Spontaneous clinical regression in chronic lymphocytic leukaemia. Br J Haematol 2002;116:341–345.
   PubMed Web of Science ®Google Scholar
• Upshaw JD Jr, Callihan TR. Spontaneous remission of B-cell chronic lymphocytic leukemia associated with T lymphocytic hyperplasia in bone marrow. South Med J 2002;95:647–649.
   PubMed Web of Science ®Google Scholar
• Rawstron AC, Bennett FL, O’Connor SJ, et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 2008;359:575–583.
   PubMed Web of Science ®Google Scholar
• Rawstron AC, Shanafelt T, Lanasa MC, et al. Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL). Cytometry B Clin Cytom 2010;78(Suppl. 1):S19–S23.
   PubMed Web of Science ®Google Scholar
• Shanafelt TD, Ghia P, Lanasa MC, et al. Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia 2010;24:512–520.
   PubMed Web of Science ®Google Scholar
• Kyle RA, Therneau TM, Rajkumar SV, et al. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood 2003;102:3759–3764.
   PubMed Web of Science ®Google Scholar
• Rajkumar SV. Prevention of progression in monoclonal gammopathy of undetermined significance. Clin Cancer Res 2009;15:5606–5608.
   PubMed Web of Science ®Google Scholar
• Ghia P, Caligaris-Cappio F. Monoclonal B-cell lymphocytosis: right track or red herring? Blood 2012;119:4358–4362.
   PubMed Web of Science ®Google Scholar
• Shanafelt TD, Witzig TE, Fink SR, et al. Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia. J Clin Oncol 2006;24: 4634–4641.
   PubMed Web of Science ®Google Scholar
• Pepper C, Thomas A, Hoy T, et al. Flavopiridol circumvents Bcl-2 family mediated inhibition of apoptosis and drug resistance in B-cell chronic lymphocytic leukaemia. Br J Haematol 2001;114:70–77.
   PubMed Web of Science ®Google Scholar
• Witzig TE, Wiernik PH, Moore T, et al. Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's lymphoma. J Clin Oncol 2009;27:5404–5409.
   PubMed Web of Science ®Google Scholar
• Winer ES, Ingham RR, Castillo JJ. PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignancies. Expert Opin Investig Drugs 2012;21:355–361.
   PubMed Web of Science ®Google Scholar
• Castillo JJ, Furman M, Winer ES. CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignancies. Expert Opin Investig Drugs 2012;21:15–22.
   PubMed Web of Science ®Google Scholar
• Dal-Bo M, Del Giudice I, Bomben R, et al. B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia:the growing saga of the IGHV3 subgroup gene usage. Br J Haematol 2011;153:3–14.
   PubMed Web of Science ®Google Scholar
• Rassenti LZ, Jain S, Keating MJ, et al. Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia. Blood 2008;112:1923–1930.
   PubMed Web of Science ®Google Scholar